Clinical trialNCT00547404WithdrawnPhase 1Interventional

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

SponsorPiramal Enterprises LimitedEnrollment35Multiple Myeloma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Noopur Raje, MD
Dana-Farber Cancer Institute
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Sagar Lonial, MD
Winship Cancer Institute,Emory University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Sundar Jagannath, MD
St. Vincent's Comprehensive Cancer Center
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

P 276-00 →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2008
Primary completion: 31 Dec 2009
Completion: 31 Jul 2010
Last update posted: 23 Apr 2009
Registered enrollment: 35
Registry id: NCT00547404

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.